If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Sara Raimondi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Meta-Analysis Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Calcitriol Receptors Medicine & Life Sciences
Genotype Medicine & Life Sciences
Odds Ratio Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Receptor, Melanocortin, Type 1 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

Genomics of non-small cell lung cancer (NSCLC): Association between CT-based imaging features and EGFR and K-RAS mutations in 122 patients—An external validation

Rizzo, S., Raimondi, S., de Jong, E. E. C., van Elmpt, W., De Piano, F., Petrella, F., Bagnardi, V., Jochems, A., Bellomi, M., Dingemans, A. M. & Lambin, P., Jan 2019, In : European Journal of Radiology. 110, p. 148-155 8 p.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
ROC Curve

How many roads lead to stillbirth rate reduction? A 30-year analysis of risk factors in a Northern Italy University care center

Raimondi, S., Mascherpa, M., Ravaldi, C., Vannacci, A., Marconi, A. M., Bulfamante, G. P. & Avagliano, L., Jan 1 2019, (Accepted/In press) In : Journal of Maternal-Fetal and Neonatal Medicine.

Research output: Contribution to journalArticle

Fetal Development

Identifying Drug Repurposing Opportunities in Oncology

Orecchioni, S., Roma, S., Raimondi, S., Gandini, S. & Bertolini, F., Mar 1 2019, In : Cancer Journal (United States). 25, 2, p. 82-87 6 p.

Research output: Contribution to journalReview article

Drug Repositioning
Pharmaceutical Preparations
Computer Simulation
Costs and Cost Analysis
Lung Neoplasms
Delayed Diagnosis

MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort

IMI Study Group, GEM Study Group & M-SKIP Study Group, May 1 2019, In : The Lancet Child and Adolescent Health. 3, 5, p. 332-342 11 p.

Research output: Contribution to journalArticle

Receptor, Melanocortin, Type 1
Odds Ratio